Epinephrine Dosing for Severe Asthma Exacerbations
For severe asthma exacerbations, subcutaneous epinephrine (concentration 1:1000) should be administered at 0.01 mg/kg, divided into 3 doses of approximately 0.3 mg given at 20-minute intervals. 1
Subcutaneous Administration
- The standard adult dose is 0.3-0.5 mg subcutaneously every 20 minutes for 3 doses 1
- For children, the dose is 0.01 mg/kg up to 0.3-0.5 mg every 20 minutes for 3 doses 1
- Although epinephrine has nonselective adrenergic properties that may increase heart rate and myocardial irritability, it is generally well-tolerated even in patients over 35 years of age 1, 2
Intravenous Administration
- For severe refractory asthma, IV epinephrine may be considered at an initial dose of 0.25-1 mcg/min as a continuous infusion 1
- Caution is warranted with IV administration as one retrospective study indicated a 4% incidence of serious side effects 1
- However, a small case series of younger adults with life-threatening asthma found IV epinephrine to be safe with no significant adverse events 3
Important Considerations
- There is no evidence that subcutaneous epinephrine has advantages over inhaled β2-agonists for asthma exacerbations 1, 4
- In patients with mild to moderate asthma, inhaled epinephrine is equally effective as injected epinephrine with fewer side effects 4
- For severe airway obstruction (PEFR <25% of predicted), parenteral epinephrine may be superior to aerosol delivery 4
- Nebulized epinephrine (1 mg) has been shown to be as effective as nebulized salbutamol (2.5 mg) in acute severe asthma 5
Treatment Algorithm
- First-line treatment: Use inhaled short-acting beta-agonists (albuterol 2.5-5 mg via nebulizer every 20 minutes for 3 doses) 6, 7
- Add ipratropium bromide (0.5 mg via nebulizer every 20 minutes for 3 doses) for severe exacerbations 6, 7
- Administer systemic corticosteroids early (prednisone 40-80 mg/day or equivalent) 6, 7
- For severe refractory asthma not responding to the above:
Cautions and Contraindications
- Do not inject epinephrine into buttocks, digits, hands, or feet 8
- Use with caution in patients with underlying heart disease, hyperthyroidism, Parkinson's disease, diabetes, and pheochromocytoma 8
- Epinephrine may interact with cardiac glycosides, halogenated hydrocarbon anesthetics, tricyclic antidepressants, and MAO inhibitors 8
- Monitor for adverse reactions including anxiety, tremor, palpitations, and arrhythmias 8